Unity Biotechnology, Inc. (UBX) Misses Q1 EPS by 59c

Unity Biotechnology, Inc. (NASDAQ: UBX) reported Q1 EPS of ($0.76), $0.59 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Unity Biotechnology, Inc. (UBX) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period